AGC Biologics and BioConnection say they offer a “gene to vial” value chain service with a single contract and project ...

The company plans to develop novel drugs that use RNA sensors to turn on therapeutic protein translation in target cells.

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, announced the signing of a definitive agreement to acquire Mirus Bio.

ASOs with modified bases and sugars can enhance the effectiveness of targeting diseases in the CNS for clinical purposes.

Mouse studies suggest PEPITEM could be used as an alternative, early clinical intervention to reverse the impact of ...

Study provides new insights into how the maternal immune response might influence brain development in embryos.

By probing the "dark genome," researchers want to provide a source of hope for patients with psychiatric disorders.

Researchers say an approach likened to “mixing console for blood systems" could have broad implications beyond hematological ...

A company founded last year is hoping to tackle a major problem in gene therapy—the failure of therapies to reach the ...

Building models is a key element of today’s science behind bioprocessing. The value of such models, however, depends on the ...

CRISPR screen uses fast-onset AAVs and a transposon system to reveal cell-type-specific transcriptional networks in cortical ...

Cell cannibalism and other cell-in-cell phenomena are widespread across the tree of life, and cell-in-cell-related genes ...